{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:58:50Z","timestamp":1761821930803,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rec.2018.08.026","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T21:20:49Z","timestamp":1543267249000},"page":"935-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants"],"prefix":"10.1016","volume":"72","author":[{"given":"C\u00e9sar","family":"Caro Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gin\u00e9s","family":"Elvira Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.","family":"Flores Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Cerezo Manchado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Albend\u00edn Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Lova Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Arregui Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcadio","family":"Garc\u00eda Alberola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo Andr\u00e9s","family":"Pascual Figal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Bail\u00e9n Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Manzano Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2018.08.026_bib0160","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2018.08.026_bib0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2018.08.026_bib0170","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2018.08.026_bib0175","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2018.08.026_bib0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCOUTCOMES.115.002369","article-title":"Dabigatran versus warfarin for atrial fibrillation in real-world clinical practice: a systematic review and meta-analysis","volume":"9","author":"Romanelli","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10.1016\/j.rec.2018.08.026_bib0185","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2018.08.026_bib0190","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.recesp.2016.09.019","volume":"70","author":"Kirchhof","year":"2017","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2018.08.026_bib0195","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/europace\/euu178","article-title":"The definition of valvular and non-valvular atrial fibrillation: results of a physicians\u2019 survey","volume":"16","author":"Molteni","year":"2014","journal-title":"Europace."},{"key":"10.1016\/j.rec.2018.08.026_bib0200","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1093\/eurheartj\/ehu352","article-title":"What is \u00abvalvular\u00bb atrial fibrillation? A reappraisal","volume":"35","author":"De Caterina","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2018.08.026_bib0205","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/europace\/eux240","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.rec.2018.08.026_bib0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.115.020950","article-title":"Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)","volume":"134","author":"Ezekowitz","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2018.08.026_bib0215","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","article-title":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial","volume":"35","author":"Breithardt","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2018.08.026_bib0220","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","article-title":"Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","volume":"132","author":"Avezum","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2018.08.026_bib0225","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jacc.2016.12.031","article-title":"Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 Trial","volume":"69","author":"De Caterina","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2018.08.026_bib0230","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2016.12.038","article-title":"Non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease","volume":"69","author":"Renda","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2018.08.026_bib0235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2018.08.026_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejechocard\/jen303","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"10","author":"Baumgartner","year":"2009","journal-title":"Eur J Echocardiogr."},{"key":"10.1016\/j.rec.2018.08.026_bib0245","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/CIR.0b013e3182831a11","volume":"127","author":"Cannon","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2018.08.026_bib0250","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.rec.2018.08.026_bib0255","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc."},{"issue":"2 Suppl","key":"10.1016\/j.rec.2018.08.026_bib0260","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.rec.2018.08.026_bib0265","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J."},{"issue":"6 Suppl","key":"10.1016\/j.rec.2018.08.026_bib0270","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest."},{"key":"10.1016\/j.rec.2018.08.026_bib0275","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.rec.2018.08.026_bib0280","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2018.08.026_bib0285","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.athoracsur.2007.04.036","article-title":"Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?","volume":"84","author":"Ngaage","year":"2007","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.rec.2018.08.026_bib0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.amjcard.2014.10.027","article-title":"Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement","volume":"115","author":"Maan","year":"2015","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2018.08.026_bib0295","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.ijcard.2013.07.017","article-title":"Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation","volume":"168","author":"Calvo","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2018.08.026_bib0300","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2018.08.026_bib0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(96)91240-4","article-title":"Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement","volume":"347","author":"Anderson","year":"1996","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2018.08.026_bib0310","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hcm076","volume":"100","author":"Hughes","year":"2007","journal-title":"QJM."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585718304365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585718304365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:57:17Z","timestamp":1761821837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585718304365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1885585718304365"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2018.08.026","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2018.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2018.08.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Cardiolog\u00eda.","name":"copyright","label":"Copyright"}]}}